Know How Bexagliflozin Stacks Up to Other SGLT2 Inhibitors
New bexagliflozin (Brenzavvy) will try to shake up the SGLT2 inhibitor market.
That’s because bexagliflozin will cost about $50/month...versus about $600/month for other SGLT2 inhibitors (dapagliflozin, etc).
But bexagliflozin won’t be covered by most payers yet...and it will only be available through a single online pharmacy at first. Expect distribution to broaden over the next couple months.
Practical advice for a better career, with unlimited access to CE
Hospital Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote